MA22.02 Activation of MAPK Suppresses Neuroendocrine Transcription Factors and Causes Transdifferentiation of Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.502
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Roles of Mitochondrial Transcription Termination Factors in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Parthenolide Suppresses Non-Small Cell Lung Cancer GLC-82 Cells Growth via B-Raf/Mapk/Erk Pathway

Oncotarget
Oncology
2017English

Correlation of Neuroendocrine Features With Prognosis of Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Casticin Suppresses the Carcinogenesis of Small Cell Lung Cancer H446 Cells Through Activation of AMPK/FoxO3a Signaling

Oncology Reports
MedicineCancer ResearchOncology
2018English

Small Cell Lung Cancer Tumors and Preclinical Models Display Heterogeneity of Neuroendocrine Phenotypes

Translational Lung Cancer Research
Oncology
2018English

Modulation of Neuroendocrine Surface Antigens in Oncogene-Activated Small Cell Lung Cancer Lines

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1991English

FSTL1 Suppresses Tumor Cell Proliferation, Invasion and Survival in Non-Small Cell Lung Cancer

Oncology Reports
MedicineCancer ResearchOncology
2017English

Neurotensin and Its Receptors Mediate Neuroendocrine Transdifferentiation in Prostate Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

miR-147a Suppresses the Metastasis of Non-Small-Cell Lung Cancer by Targeting CCL5

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy